Peptide, preparation and pharmaceutical composition — US6248716B1
Patent disclosure · 2001
- What the patent describes
- Broad peptide-analogue patent with multiple animal experiments; the selected numerical example concerns cattle growth.
- Reported evidence
- The Sedatin patent documents Arg–Tyr–D-Ala–Phe–Gly and related peptide chemistry. Related scaffold claims in RU2067000C1 do not establish that every possible A-number was synthesized or tested.
Cattle weight gain · 233.2 ± 2.4 kg treated versus 189.0 ± 2.7 kg control; 12 animals/group · Starting weights 72.3 ± 0.9 and 72.2 ± 1.1 kg; not human therapeutic benefit
Reported patent results
Reported findings
A preparation tested in the patent was associated with greater weight gain in a small animal-production comparison.
Broad peptide-analogue patent with multiple animal experiments; the selected numerical example concerns cattle growth.
Population or model Broad peptide-analogue patent with multiple animal experiments; the selected numerical example concerns cattle growth.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Cattle weight gain | 233.2 ± 2.4 kg treated versus 189.0 ± 2.7 kg control; 12 animals/group | Starting weights 72.3 ± 0.9 and 72.2 ± 1.1 kg; not human therapeutic benefit |
| Daily gain | 752 ± 17.3 g/day versus 610 ± 15.8 g/day | Same cattle example; observation duration not independently entered |
The broad patent contains different peptide constructs and experiments. This animal example cannot establish a human anti-stress effect or be assigned to every Sedatin/dermorphin analogue.
Source for these results ↗ · Reviewed 2026-11-06
Patent claims and provenance
Use. Stress-related method claims involving defined peptide analogues in the sedatin/dermorphin research trail; sequence and terminal modifications limit transfer to other analogues.
A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.
- Publication
- US6248716B1 ↗ · 2001-06-19
- Earliest priority / filing
- 1995-06-27 / 1999-05-27
- Original applicant / assignee
- Immunotech Developments Inc
- Indexed status
- Expired - Lifetime · checked 2026-11-06
- Patent family
- 27082120 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
Inventors: Vladislav I. Deigin; Elena P. Yarova.
Study limitations and source details
Study limitations
- No clinical benefit or regulatory approval inferred from patent grant.
Source details
Selected original-source text checked; full methodological review pending.
Selected reported results and source limitations reviewed; not a complete risk-of-bias or experimental audit.
Sources checked
Citation
Author unconfirmed. Peptide, preparation and pharmaceutical composition — US6248716B1 Primary source linked above